Health
Health
10 projects · €26,753,292 total EU contribution (project-level) · 70 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€26,753,292
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (13)
- Germany (10)
- France (10)
- Netherlands (8)
- Italy (5)
- BE (4)
- CH (3)
- HU (2)
- SE (2)
- US (2)
- AT (1)
- CA (1)
- CZ (1)
- DK (1)
- Spain (1)
- IE (1)
- IL (1)
- LV (1)
- PL (1)
- SI (1)
- SN (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- IP4 projects · FR
- BNI3 projects · DE
- INSERM3 projects · FR
- DH2 projects · UK
- INMI2 projects · IT
- UOXF2 projects · UK
- THE UNIVERSITY OF LIVERPOOL2 projects · UK
- AMU2 projects · FR
- ABSISKEY1 projects · FR
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- Leiden University Medical Center1 projects · NL
- MSF1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Human Puripotent Stem Cell Registry hPSCreg · 726320 | H2020 | €1,000,000 | €728,802 | Details |
European Consortium for Communicating Stem Cell Research EuroStemCell · 652796 | H2020 | €600,000 | €112,500 | Details |
Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management EVIDENT · 666100 | H2020 | €1,759,325 | €72,000 | Details |
Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy IF-EBOla · 666102 | H2020 | €1,992,770 | €360,895 | Details |
High Level eHealth Conference 2015 EHW15 · 685436 | H2020 | €300,000 | €312,399 | Details |
eHealth Week 2016 eHealth Week · 731116 | H2020 | €300,000 | €342,020 | Details |
Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries. Ebola_Tx · 666094 | H2020 | €2,892,171 | €1,907,477 | Details |
Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) during Ebola virus infection in non-human primates humans REACTION · 666092 | H2020 | €2,575,810 | €86,191 | Details |
Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine EbolaVac · 666085 | H2020 | €15,153,216 | €107,500 | Details |
Global Alliance for Chronic Diseases Secretariat GACD · 661024 | H2020 | €180,000 | €180,000 | Details |